| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceb2504c8d821ee1e5dd0861abee6d7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9542003c453b6819b54edc0a6df7c17f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ff09660412656461562484438fcc96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a2fb52658a299ecffedcf8681720641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38ff118de0980c8060fab957aa6b3d63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d59d13f2d2e6ebdbc1d39a1773ce450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3230c73f9e8ef0ab4384e11d7c2963b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba84704f5ec05a8c58c4c39b7e07d96 |
| publicationDate |
2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202034953-A |
| titleOfInvention |
Anti-podoplanin antibody |
| abstract |
The subject of the present invention is to provide a humanized antibody or mouse-human chimeric antibody as an anti-Platin antibody or an antibody fragment containing the antigen-binding region of the anti-Platin antibody, by including a predetermined amino acid The sequence and isolation of an anti-Platin antibody as a humanized antibody or a mouse-human chimeric antibody or an antibody fragment containing the antigen binding region of the Anti-Platin antibody solves the problem. |
| priorityDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |